指南与共识姑息放疗与转移瘤放疗物理与技术

采用国际共识疼痛缓解标准评估骨转移常规放射治疗后疼痛缓解率:初始放疗与再程放疗的系统综述与Meta分析

Pain Response Rates After Conventional Radiation Therapy for Bone Metastases Assessed Using International Consensus Pain Response Endpoints: A Systematic Review and Meta-Analysis of Initial Radiation Therapy and Reirradiation.
指南 / 共识 · Int J Radiat Oncol Biol Phys · 2023-02-02

该系统综述与Meta分析检索2002年至2021年PubMed与Scopus数据库,纳入采用国际共识疼痛缓解标准(ICPRE)评估疼痛缓解的前瞻性研究或基于前瞻性收集数据的研究,分析初始放疗与再程放疗的总体缓解率。初始放疗可评估患者(n=4775)与意向治疗患者(n=6775)的总体缓解率分别为60.4%(95%CI 55.2-65.4)与45.4%(95%CI 38.7-52.4);再程放疗可评估患者(n=733)与意向治疗患者(n=1085)的总体缓解率分别为70.8%(95%CI 15.7-96.9)与62.2%(95%CI 5.3-98.0)。初始放疗的ICPRE评估缓解率低于既往报道,再程放疗的宽置信区间表明基于ICPRE的缓解率需进一步研究。

要点

  • 初始放疗可评估患者总体缓解率60.4%(95%CI 55.2-65.4),意向治疗患者45.4%(95%CI 38.7-52.4)。
  • 再程放疗可评估患者总体缓解率70.8%(95%CI 15.7-96.9),意向治疗患者62.2%(95%CI 5.3-98.0)。
  • 初始放疗亚组分析中随机与非随机研究比较均无显著差异,提示不同研究设计间缓解率相似。

核心结论

  • 初始放疗的ICPRE评估缓解率低于既往报道,总体缓解率与完全缓解率应作为未来随机与非随机研究的基准。
  • 再程放疗的宽置信区间表明基于ICPRE的缓解率需进一步研究。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed与Scopus数据库2002年至2021年发表的文章。
  • 纳入标准为前瞻性研究或基于前瞻性收集数据的研究,且疼痛缓解采用国际共识疼痛缓解标准(ICPRE)评估。
  • 共鉴定6470篇文章,其中32篇符合初始放疗分析纳入标准,3篇符合再程放疗分析纳入标准。

主要发现

  • 初始放疗可评估患者(n=4775)总体缓解率为60.4%(95%CI 55.2-65.4),意向治疗患者(n=6775)为45.4%(95%CI 38.7-52.4)。
  • 再程放疗可评估患者(n=733)总体缓解率为70.8%(95%CI 15.7-96.9),意向治疗患者(n=1085)为62.2%(95%CI 5.3-98.0)。
  • 初始放疗亚组分析包括随机与非随机研究比较,任何比较均无显著差异,提示不同研究设计间缓解率相似。

关键数值与推荐

  • 疼痛缓解采用国际共识疼痛缓解标准(ICPRE)评估。
  • 主要结局为初始放疗与再程放疗的总体缓解率(完全缓解率与部分缓解率之和)。

局限性

  • 再程放疗的宽置信区间表明基于ICPRE的缓解率需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Previous meta-analysis of conventional radiation therapy for painful bone metastases showed overall response (OR) rates of 72% to 75% (evaluable patients), 61% to 62% (intent-to-treat patients) for initial radiation therapy, and 68% for reirradiation (evaluable patients). However, the definition of pain response differed among the studies included. Hence, we conducted a systematic review and meta-analysis to determine the pain response rates assessed by the International Consensus Pain Response Endpoints (ICPRE) for both initial radiation therapy and reirradiation. The PubMed and Scopus databases were searched for articles published between 2002 and 2021. The inclusion criteria were (1) prospective studies or studies based on prospectively collected data and (2) studies in which pain response was assessed using ICPRE. Our primary outcomes of interest were the OR rates (sum of the complete and partial response rates) for both initial radiation therapy and reirradiation. Of the 6470 articles identified in our database search, 32 and 3 met the inclusion criteria for the analysis of initial radiation therapy and reirradiation, respectively. The OR rates of initial radiation therapy in evaluable patients (n = 4775) and intent-to-treat patients (n = 6775) were 60.4% (95% confidence interval [CI], 55.2-65.4) and 45.4% (95% CI, 38.7-52.4), respectively. The OR rates of reirradiation in evaluable patients (n = 733) and intent-to-treat patients (n = 1085) were 70.8% (95% CI, 15.7-96.9) and 62.2% (95% CI, 5.3-98.0), respectively. Subgroup analyses of initial radiation therapy including the comparison of randomized and nonrandomized studies showed no significant differences in any comparison, indicating similar response rates across different study designs. For initial radiation therapy, we determined the ICPRE-assessed response rates, which were lower than previously reported. The OR and complete response rates should be benchmarks for future randomized and nonrandomized studies. For reirradiation, the wide CIs demonstrate that the response rates based on ICPRE require further investigation.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Imano N, Saito T, Hoskin P, et al. Pain Response Rates After Conventional Radiation Therapy for Bone Metastases Assessed Using International Consensus Pain Response Endpoints: A Systematic Review and Meta-Analysis of Initial Radiation Therapy and Reirradiation. Int J Radiat Oncol Biol Phys. 2023. PMID: 36736920. doi:10.1016/j.ijrobp.2023.01.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。